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Abstract 
Chronic exposure to household indoor smoke and outdoor air pollution is a major contributor to global morbidity 
and mortality. The majority of these deaths occur in low and middle‐income countries. Children, women, the elderly 
and people with underlying chronic conditions are most affected. In addition to reduced lung function, children 
exposed to biomass smoke have an increased risk of developing lower respiratory tract infections and asthma-related 
symptoms. In adults, chronic exposure to biomass smoke, ambient air pollution, and opportunistic exposure to 
fumes and dust are associated with an increased risk of developing chronic bronchitis, chronic obstructive pulmo-
nary disease (COPD), lung cancer and respiratory infections, including tuberculosis. Here, we review the evidence of 
prevalence of COPD in people exposed to non-cigarette smoke. We highlight mechanisms that are likely involved in 
biomass-smoke exposure-related COPD and other lung diseases. Finally, we summarize the potential preventive and 
therapeutic strategies for management of COPD induced by non-cigarette smoke exposure.
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Introduction
Worldwide, in 2016, approximately 9 million deaths were 
attributed to lung diseases, including COPD, lung can-
cer and lower respiratory tract infections, among which 
82.4% occurred in low and middle-income countries [1]. 
Tobacco smoking is one of the most well-characterized 
risk factors for lung disease  development, killing more 
than 7 million people each year [2]. However, compared 
to 1.1 billion tobacco smokers globally, nearly 3 billion 
people are exposed to biomass smoke [3, 4]. Moreo-
ver, data from epidemiologic studies conducted in Asia, 
Europe, South America and Africa have consistently 
shown associations between biomass smoke exposure 
and lung diseases, even after controlling for the primary 
risk factor, tobacco smoking [5, 6]. Here, we review the 
association of lung diseases, including COPD, with expo-
sure to biomass smoke, fumes, dust, gases and outdoor 
air pollution.
Methods
We conducted a qualitative examination of the pub-
lished peer-reviewed literature from 1980 to June 2018 
using the Medline database (https ://www.nlm.nih.gov/
bsd/medli ne.html). We used the search terms “biomass 
fuel”, “biomass smoke”, “wood smoke”, “solid fuel”, “coal 
smoke”, “indoor smoke”, household pollutants”, “outdoor 
air pollution”, “occupational exposure” combined using 
the Boolean logic ‘OR’. Similarly, the search terms “lung 
disease”, “pulmonary disease”, “airway disease”, “bron-
chitis”, “emphysema”, “asthma”, “lung cancer”, “acute res-
piratory tract infection” were also combined using the 
Boolean logic ‘OR’. The two subsets were combined using 
the Boolean logic ‘AND’, and the results were restricted 
to meta-analyses, systematic reviews, observational stud-
ies, comparative studies and original articles published 
in English. The search resulted in 1953 articles that were 
screened from which 168 studies were selected as being 
relevant to the review.
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Prevalence and burden of biomass smoke exposure
Annually, nearly 4 million people die prematurely from 
illness attributable to household biomass smoke expo-
sure, among which an estimated 55% die due to respira-
tory diseases, including pneumonia (lower respiratory 
tract infections), COPD and lung cancer [7]. Nearly half 
of the world’s population rely on biomass, such as wood, 
animal dung, and crop residues as a primary fuel source 
for cooking and heating purposes [7]. The proportion 
of households using clean fuels (liquid petroleum gas, 
biogas and electricity) varies considerably across the 
globe (and even in the same continent) [8]. The access to 
clean fuels is especially limited to relatively smaller popu-
lations in the low- and middle-income countries (Fig. 1). 
Consequently, populations residing in the regional and 
rural households in developing countries are heavily 
reliant on biomass fuel for cooking or heating purposes 
(Fig. 1) [9].
The particular concern with energy from biomass fuel 
is the use of inefficient stoves for combustion, which 
generates toxic gases like carbon monoxide and nitrogen 
oxides; suspended particulate matter containing volatile 
organic compounds (VOCs) such as methane, aldehydes, 
benzene and its derivatives; and polycyclic aromatic 
hydrocarbons (PAHs) like benzo[a]pyrene and anthra-
cene [10]. Particulate matter (PM) with an aerodynamic 
diameter of < 2.5 microns  (PM2.5) is light and can remain 
suspended in the air for longer periods [11]. These par-
ticles can be inhaled deep into the lungs, and have been 
linked to oxidative stress and inflammation induced dam-
age of the respiratory system [11]. Moreover, in develop-
ing countries, the cultural practice of indoor cooking 
in housing with poor air ventilation potentially exposes 
women and children to  PM2.5 up to the levels that are 
1000 times higher than the threshold recommended by 
WHO (25 µg/m3) [12, 13].
Wood is the most common biomass fuel, however, 
use of animal dung, such as cow, sheep and horse, as 
a  source of fuel is also widespread, especially in rural 
areas of low- and middle-income countries, including 
Fig. 1 Global use of clean fuels in 2014, by the World Health Organization. Countries with the lowest (< 5%) and the highest (> 95%) proportion of 
people using clean fuels as the primary domestic source of energy are shaded dark and light blue, respectively. Reproduced with permission from 
the World Health Organization [8], Copyright (2016)
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India, Nepal, and sub-Saharan Africa due to its avail-
ability in areas with limited vegetation and its lower 
cost [14]. Despite this, animal dung is the least effi-
cient biofuel and burns faster as compared to wood 
[15]. Relative to wood smoke, combustion of animal 
dung produces more particulate matter (23% more 
 PM2.5 per kilogram), toxic byproducts, such as PAHs 
and oxidizing species, such as redox active metals 
(copper and iron) and quinones [16, 17].
Nonetheless, exposure to biomass smoke is not 
exclusively an issue in low- and middle-income coun-
tries. Use of indoor wood fires for heating purposes 
and for imparting flavor during cooking processes, 
such as barbecuing and wood-smoking of food, is 
becoming more popular in high-income countries, 
thus, increasing biomass smoke exposure [18]. In 2014, 
in a survey carried out in Australia, approximately 10% 
of households used wood as the main source of heating 
[19]. However, in developed countries, use of biomass 
fuel is primarily seasonal and exposure is largely lim-
ited by better ventilation [20]. Besides indoor biomass 
smoke exposure, people in developed countries such 
as Australia, Canada and the USA are also exposed to 
outdoor biomass smoke from frequent bushfires [21]. 
Importantly, individuals exposed to biomass smoke are 
more likely to have respiratory symptoms and reduced 
lung function [22–24].
Association of biomass smoke exposure 
with respiratory diseases
Chronic airway disease
Worldwide, COPD claimed more than 3 million deaths 
in 2016, among which 81.8% occurred in low- and mid-
dle-income countries [1]. Tobacco smoking is still the 
main causative factor of COPD in high-income coun-
tries where only 15–25% of COPD cases are never smok-
ers (Table  1). However, in low and middle countries 
more than 45% of COPD patients have been found to 
be never smokers (Table  1). The existing literature pro-
vides strong evidence that smoke from biomass fuels is 
an independent risk factor for the development of COPD, 
particularly in low- and middle-income countries where 
the reliance on biomass fuel is still very high. The nox-
ious particles in biomass smoke induce an inflammatory 
response through: upregulation of pro-inflammatory 
cytokines such as interleukin 6 (IL-6), tumor necrosis 
factor alpha (TNFα), and granulocyte colony stimula-
tory factor (G-CSF); recruitment of immune cells, such 
as macrophages and neutrophils; upregulation of gelati-
nases (matrix metalloproteinase 2 and 9); and epithelial-
mesenchymal transition (EMT), thereby reducing lung 
function and contributing to the onset/progression of 
COPD [25–27]. Da Silva et al. in a case–control study in 
Brazil, evaluated the effect of exposure to biomass com-
bustion  PM2.5 on lung function [22]. There was a signifi-
cant loss in pulmonary function in non-smoker biomass 
users compared to non-smoker liquefied petroleum gas 
(LPG) users (forced expiratory volume in one second to 
Table 1 Proportion of never smokers among COPD patients and associated risk factors
ECRHS European Community Respiratory Health Survey; CS cross-sectional study; CPH China Pulmonary Health; COPD chronic obstructive pulmonary disease
Study center and design Participants Age (years) Proportion 
of never smokers 
among COPD patients (%)




Multinational (35 centres, 16 
countries; ECRHS)
17,966 20–44 17.0 13.4 21.6 Occupational exposure to 
vapours, gas, dust, or fumes
Cerveri et al. [33]
Malataya, Turkey (CS) 1160 > 18 22.5 Exposure to biomass smoke Gunen et al. [34]
China (CPH; nationwide CS) 50,991 > 20 50.5 10.1 91.7 Exposure to biomass fuel smoke 
and  PM2.5, parental history of 
respiratory disease
Wang et al. [28]
South Africa (nationwide survey) 13,826 > 18 47·6 24.8 61.0 Biomass fuel, occupational 
exposure, history of pulmonary 
tuberculosis
Ehrlich et al. [35]
Maswa, Tanzania (CS) 869 > 35 62.1 – – Magitta et al. [36]
Västra Götaland and Norrbotten, 
Sweden (CS)
1839 21–78 21 – – Occupational exposure to gas, 
dust and fumes
Hagstad et al. [37]
Copenhegen, Denmark (CS) 68,501 20–100 22.3 18.9 25.5 Thomsen et al. [38]
Multinational 12 countries; 
population-based survey)
73,745 > 40 36 (24 
USA-64 
Mexico)
21 49 Landis et al. [39]
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forced vital capacity ratio  (FEV1/FVC) 0.79 versus 0.85, 
p < 0.05, respectively). In addition, pulmonary function 
was negatively correlated with the level and  duration 
of  PM2.5 exposure  (FEV1/FVC: r = − 0.63, p < 0.05 and 
− 0.52, p < 0.05, respectively) [22]. A minor reduction in 
 FEV1/FVC was observed in women in Mexico using bio-
mass fuel compared to clean gas (0.80 vs 0.83, p = 0.03, 
respectively) [24].
In a recent nationwide cross-sectional study conducted 
in 50,991 individuals from ten provinces of China, more 
than half of the COPD patients were never smokers [28]. 
Importantly, the proportion of never smokers in female 
COPD patients was markedly high (91.7%). Addition-
ally, individuals exposed to indoor biomass smoke were 
62% more likely to develop COPD than unexposed indi-
viduals who used clean fuel sources (age and sex adjusted 
OR = 1.6, p = 0.003) [28].
A meta-analysis of 11 cross-sectional and four case–
control studies covering a wide range of countries 
identified household biomass smoke exposure as an inde-
pendent risk factor for developing COPD in both men 
(OR 4.30, 95% CI 1.85–10.01) and women (OR 2.73, 95% 
CI 2.28–3.28), and in both the Asian population (OR 
2.31, 95% CI 1.41–3.78) and the non-Asian population 
(OR 2.56, 95% CI 1.71–3.83) [5]. This finding is supported 
by another recent cross-sectional study, the PUMA 
(Prevalence Study and Regular Practice, Diagnosis, and 
Treatment Among General Practitioners in Populations 
at Risk of COPD in Latin America), which assessed 1740 
individuals from multiple nations in South America, who 
were at greater risk of developing COPD [6]. The PUMA 
study reported that individuals exposed to household 
biomass smoke are twice as likely to develop COPD than 
unexposed people (adjusted OR 2.28, 95% CI 1.18–4.41) 
[6]. Moreover, a systematic review of 24 epidemiological 
studies revealed that household biomass smoke exposure 
was associated with COPD development in both urban 
(OR 1.6, 95% CI 1.2–2.0) and rural women (OR 2.0, 95% 
CI 1.5–2.8) [29].
In terms of COPD phenotypes, biomass smoke exposed 
individuals were found to have more lung fibrosis and 
bronchiolitis and less emphysema whereas  tobacco 
smokers exhibited higher levels of emphysema  (radiolo-
gist CT score—a measure of the extent of emphysema 
based on computed tomography (CT) at inspiration and 
expiration) 0.7 versus 2.3, p = 0.001; emphysema on CT 
19% versus 27%, p = 0.046) [30, 31]. This finding is fur-
ther supported by Fernandes et  al. who reported a  sig-
nificantly lower level of emphysema in biomass exposed 
women than in  women who were tobacco smokers 
 (PRMEmph (parametric response mapping, an image tool 
used to quantify emphysema based on paired CT images 
at inspiration and expiration) 1.84% (0.69 ± 3.72%) versus 
9.85% (2.40–16.34%); p = 0.001) [32].
Lung cancer
Globally, 1.7 million deaths in 2016 were attributed to 
lung cancer, among which 66% occurred in low- and 
middle-income countries [1]. The combustion products 
of biomass fuel emissions such as dibenz[a,h]anthra-
cene, cyclopenta[cd]pyrene and 1,3-butadiene have been 
grouped as a probable human carcinogen (group 2A) by 
the International Agency for Research on Cancer [40]. 
Saldana and colleagues, in a hospital based case–con-
trol study with 136 cases of primary lung cancer and 
137 controls, reported a significant association between 
the magnitude of biomass smoke exposure in hour-years 
(years of exposure multiplied by average hours of expo-
sure per day) and the risk of lung cancer after adjusting 
for sex, smoking, socioeconomic status and housing with 
asbestos sheet roof (OR for an exposure > 300  h-years 
3.01, 95% CI 1.12–8.36) [41]. A systematic review includ-
ing 13 case control studies summarized an increased 
risk (OR 1.17, 95% CI 1.01–1.37) of lung cancer with 
biomass exposure associated with cooking/heating, in 
particular, among women in developing countries [42]. 
In a retrospective cohort study conducted in Xuanwei 
city of China, mortality from lung cancer was compared 
between lifelong users of smoky coal (27,310 individu-
als) and smokeless coal (9962 individuals). Individuals 
exposed to smoky coal were at greater risk of death from 
lung cancer when compared to those exposed to smoke-
less coal (for men, HR 36, 95% CI 20–65; for women, 99, 
95% CI 37–266) [43]. A similar observation was reported 
in a meta-analysis from 28 epidemiological studies where 
a significantly higher risk of lung cancer was observed in 
females (OR 1.81, 95% CI 1.54–2.12; p = 0.034) exposed 
to biomass/solid fuel smoke compared to males (OR 
1.16, 95% CI 0.79–1.69) with related exposure [44]. The 
increased susceptibility of women to biomass/coal car-
cinogens compared to men may be due to differences in 
base-line exposure (women being exposed to biomass/
coal smoke for extended periods of time) or due to dif-
ferences in lung size (women having smaller lungs than 
men, hence more damage done for the similar amount 
of smoke inhaled) [45]. The association was even more 
prominent in individuals using coal (OR 1.82, 95% CI 
1.60–2.06) compared to biomass (OR 1.50, 95% CI 1.17–
1.94), which may be due to the production of predomi-
nant Group 1 carcinogenic PAHs during coal combustion 
[44, 46]. Although the studies included in this review 
have either been adjusted for smoking or studied a popu-
lation of non-smokers, none of these studies commented 
on the presence of other co-morbid conditions, such as 
COPD, at the time of lung cancer diagnosis.
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Lower respiratory tract infections
In addition to COPD and lung cancer, the other major 
respiratory cause of global mortality is lower respiratory 
tract infection (LRI) and tuberculosis, which was directly 
implicated in 2.96 and 1.29 million deaths in 2016, 
respectively [1]. Of the approximate  4 million deaths 
globally, around 89%  of the mortality was reported in 
low- and middle-income countries alone [47]. An evalu-
ation of 14 studies in developing countries indicates that 
young children living in households where biomass fuels 
are utilized, have a two to three times higher risk of res-
piratory infections than unexposed children after adjust-
ment of potential confounding factors [48, 49]. A recent 
systematic review of 77 studies from 39 low- and middle-
income countries evaluated the risk factors for mortality 
from acute lower respiratory infections in children under 
5 years of age and found that biomass smoke exposure is 
significantly associated with an increased risk of death 
from LRI (OR 3.0, 95% CI 2.1–4.3) [50]. However, only 
a small number of studies have focused on the  associa-
tion between biomass smoke exposure and risk of lower 
respiratory tract infection in the adult population. Ezzati 
et al. evaluated the risk of LRI in 229 individuals between 
5 and 49 years of age in Central Kenya upon exposure to 
biomass fuel derived  PM10 [51]. The risk of LRI was posi-
tively correlated with the level of  PM10 exposure, how-
ever, the odds ratio was significant only above 2000 µg/
m3 (adjusted OR 3.3, 95% CI 1.1–9.9) [51]. Exposure to 
household biomass smoke was associated with risk of 
hospitalization due to pneumonia in older adults aged 65 
and above (adjusted OR 3.3, 95% CI 1.6–6.9) [52]. On the 
other hand, although the prevalence of acute respiratory 
infection was higher among biomass users (15–45%), 
after controlling for major confounding factors such as 
age and smoking, the risk of LRI was not significant when 
including adults aged less than 65 [53–55]. In addition, 
biomass smoke exposure is significantly associated with 
the risk of developing tuberculosis. For example, a close 
correlation between biomass fuel usage and tuberculo-
sis (OR 3.14, 95% CI 1.15–8.56) has been reported from 
northern India compared to usage of liquid petroleum 
gas in kitchens after adjusting for confounding variables, 
such as tobacco smoking and close contact with TB cases 
(6).
Other respiratory conditions
Several studies have highlighted the effect of biomass 
smoke exposure in respiratory symptoms, such as cough, 
wheeze, mucus overproduction and dyspnoea [22–24]. A 
case–control study in Brazil reported an increased risk 
of developing chronic cough (OR 2.9, 95% CI 1.68–5.10), 
wheeze (OR 2.33, 95% CI 1.25–4.38) and dyspnoea (OR 
2.59, 95% CI 1.32–5.09) in adults exposed to biomass 
smoke as compared to LPG users [22]. Similarly, a study 
in Eastern India assessed the impact of chronic exposure 
to indoor biomass smoke on respiratory health in 681 
non-smoking women and 438 age matched women not 
exposed to biomass smoke [23]. Compared to LPG users, 
biomass users had a higher prevalence of cough, mucus 
production and wheeze (71.8% versus 30.8%, p = 0.001), 
and dyspnoea (58.4% versus 19.9%, p = 0.001) [23].
Besides lower respiratory tract symptoms, other lung 
diseases, such as asthma and pneumoconiosis have been 
correlated with exposure to indoor biomass smoke. Olu-
wole et  al. reported an increased prevalence of asthma-
related symptoms, such as wheezing or whistling in 
the chest, cough, dyspnoea and chest tightness in rural 
school children in Nigeria exposed to biomass smoke 
(OR 2.37, 95% CI 1.16–4.84) [56]. However, evidence of 
its association with asthma is inconclusive. A meta-anal-
ysis of 25 studies did not find any significant association 
of biomass smoke exposure and asthma in children (OR 
0.5, 95% CI 0.1–2.0) or women (1.34, 95% CI 0.9–1.9) 
[57]. However, a significant difference has been reported 
between bronchiectasis (diagnosed by computed tomog-
raphy scans) in women and exposure to biomass fuel, 
compared to exposure to tobacco smoke (14% versus 0%, 
p = 0.009) [30]. Particularly, the “Hut lung disease” or 
domestically acquired pneumoconiosis has been noted as 
a particulate lung disease in women exposed to biomass 
fuel smoke or agricultural activities but not associated 
with mining [58–60].
Exposure to other types of air pollutants
Environmental exposure to noxious particles and gases
High levels of air pollution have also been implicated as 
risk factors for the development of COPD, although it is 
less potent than active smoking. Approximately 25–60% 
of COPD patients are never-smokers in developing coun-
tries [28, 36, 61]. Increasing population, urbanization, 
economic profile and pollution are several factors that 
contribute substantially to the COPD burden [62]. The 
role of outdoor air pollution (including traffic-related fine 
particulate matter) as a causative factor for airflow limita-
tion is gaining attention in recent times, due to increased 
vehicular pollution, as well as industrialization of the two 
most populated countries, China and India [63].
PM2.5 is considered to be the most health-damaging of 
the particulate matter, as it can penetrate deep into 
the  lungs and initiate deleterious effects on the airway, 
including but not limited to airway oxidative stress, pul-
monary and systemic inflammation, ciliary dysfunction, 
amplification of infections, and increases in bronchial 
reactivity [64]. The main components of  PM10 are sulfate, 
nitrates, ammonia, sodium chloride, black carbon, min-
eral dust and water [4].
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Several investigators have assessed the effect of air pol-
lution as a potential risk factor for COPD. In children 
and young adults, cross-sectional studies have shown 
a relationship between higher outdoor pollutant levels 
(especially traffic related pollution) and lower lung func-
tion [65, 66]. Kulkarni et  al. reported a likely causative 
dose-dependent inverse association between the carbon 
content (as a biomarker of particulate matter exposure, 
 PM10) of airway macrophages with lung function in chil-
dren [67]. Furthermore, exposure to traffic-related pol-
lution, indicated by residential distance from a highway, 
was associated with impaired lung growth and lung func-
tion deficits at 18  years of age [68]. Also, higher traffic 
density and proximity to highways was significantly asso-
ciated with lower lung function  (FEV1) and FVC, but only 
in females [69], who are also at a greater risk of develop-
ing COPD than for those living farther away [70].
Long-term exposure to airborne particles and particu-
late matter is significantly associated with the risk of pre-
mature death and acute care hospitalizations, especially 
in patients with severe disease [71, 72]. Moreover, daily 
variation in exposure to outdoor air pollution (mainly 
the particulate matter) significantly correlates with 
acute exacerbations of COPD [73]. The mechanisms that 
underlie obstruction due to air pollution are likely to be 
similar to those caused by cigarette smoking, but we do 
not yet have conclusive evidence for this, despite the det-
rimental effects of air pollution on lung health.
Occupational exposure to dusts and fumes
Several longitudinal studies have shown an associa-
tion between certain dusty occupational exposures and 
COPD, i.e., coal mining [74], gold mining [75], work 
related to tunnel-construction [76], low levels of con-
crete dust containing crystalline silica exposure (concrete 
production industries) [77], exposure to cotton in textile 
industries [78], workers exposed to welding fumes [79], 
grain handlers and postal workers (exposure to endo-
toxins) [80] and animal feed industry [81]. Moreover, 
chronic exposure to metallic dust (primarily, cobalt and 
chromium) was found to be associated with deterioration 
of lung function [82]. In addition, exposure to chemical 
vapors, irritants and fumes can also contribute to acceler-
ated loss of airflow [83]. Another study involving railroad 
workers reported a positive association between COPD 
mortality and occupational exposure to diesel exhaust 
[84]. A population-based study found positive associa-
tions between several occupational exposure measures 
(mineral dusts, metal dusts and fumes, organic dusts, 
irritant gases or vapors, sensitizers, organic solvents, 
diesel exhaust, and environmental tobacco smoke) with 
COPD, among both ever-smokers and never-smokers 
[85].
Experimental studies in animal models have demon-
strated that exposures to several agents, such as sul-
phur dioxide, mineral dusts, vanadium and endotoxin, 
are capable of inducing chronic obstructive bronchitis 
[83]. Intratracheally instilled silica (quartz) produces air-
flow obstruction (functional change), which correlates 
with the presence of both emphysema and small-airway 
lesions [86]. Inorganic dusts containing silica are also 
associated with neutrophil and macrophage accumu-
lation and morphological changes in the rat lung [86]. 
These morphological changes in small airways and lung 
parenchyma were similar to those in rats treated with 
elastase, which represents a well-established model of 
experimental COPD [87].
Mechanisms of lung damage due to biomass 
smoke exposure
Despite the immense burden of chronic airway disease, 
only a limited number of mechanistic studies have exam-
ined the immunomodulatory effects of biomass smoke 
exposure. Sussan et al. explored the mechanisms of pul-
monary responses in mice after acute (6 and 24 h) or sub-
chronic (3 times a week for 8 weeks) exposure to wood or 
cow dung PM [17]. Acute exposure to wood smoke elic-
ited a stronger pro-inflammatory response, as indicated 
by increased expression of G-CSF, Keratinocyte chem-
oattractant (KC), C-X-C motif chemokine 10 (CXCL10), 
IL-6, TNFα and interleukin 12 p70 subunit (IL12p70) 
[17]. The induction of pro-inflammatory cytokine expres-
sion was higher with cow dung than wood smoke PM 
[17]. On the other hand, sub-chronic exposures exhibited 
differences in pulmonary response, where wood smoke 
elicited an eosinophilic response in contrast to a pre-
dominantly neutrophilic response induced by cow dung 
smoke [17]. The inflammatory response elicited by both 
wood and cow dung smoke was mediated via nuclear 
factor kappa B (NF-κB) signaling [17]. In addition, in an 
in  vitro study, c-Jun N-terminal kinase-activator pro-
tein-1 (JNK-AP-1) signaling, and not the  NFκB regula-
tory  pathway, was found to be involved in mediating 
inflammatory responses in human primary small airway 
epithelial cells upon exposure to dung biomass smoke 
[88].
Moreover, in a case–control study conducted in India 
with 142 biomass users and 126 age-matched LPG user 
women, a significant neutrophilic inflammatory response 
was observed in the  biomass using group [89]. Also, 
compared to LPG users, reactive oxygen species (ROS) 
generation by leukocytes (in both blood and sputum) 
and the systemic level of antioxidant enzyme superox-
ide dismutase (SOD) were higher and lower, respectively 
in women using biomass fuel [89]. A similar increase in 
systemic oxidative stress was reported in rats exposed to 
Page 7 of 12KC et al. Clin Trans Med            (2018) 7:39 
biomass smoke, as indicated by an increased plasma level 
of malondialdehyde and a reduced level of SOD [90]. Sev-
eral in  vitro studies reported depletion of antioxidants, 
such as ascorbate, urate and reduced glutathione in res-
piratory tract lining fluid when incubated with wood and 
animal dung smoke extracts [16, 91]. Therefore, biomass 
smoke exposure induces inflammation and oxidative 
stress mediated lung damage which  potentially contrib-
utes to the development/progression of COPD.
In terms of lung cancer, biomass smoke induced ROS 
directly damages DNA and promotes lung cell prolif-
eration and turnover, resulting in fibrosis and develop-
ment of lung tumours in rats [92]. Furthermore, biomass 
exposure upregulates the production of extracellular 
matrix proteins, including perlecan and fibronectin with 
a capacity to induce fibrosis in cultured cells [93]. In 
addition, PAHs released by incomplete combustion of 
biomass fuels are evidently carcinogenic in both in vitro 
and in  vivo studies [94–97]. Metabolism of PAHs leads 
to the formation of active carcinogens diol-epoxides, 
radical cations and o-quinones [94, 98]. These activated 
PAH metabolites can form adducts with DNA, resulting 
in mutations, alteration of gene expression profiles, and 
tumorigenesis [94]. Gene ‘hotspots’ for adduct formation 
by PAH metabolites include oncogenes such as p53, K-ras 
and the H-ras [99, 100]. PAH-DNA adducts are associ-
ated with a two-fold increased risk of lung cancer [101].
Biomass smoke exposure is also implicated in increased 
susceptibility to bacterial infection through several 
mechanisms, including alterations in alveolar mac-
rophage phagocytosis and/or upregulation of host sur-
face receptors on the respiratory epithelium [102, 103]. 
In an in  vitro study, the phagosomal function of wood 
smoke particle exposed human alveolar macrophages was 
tested with respect to uptake of fluorescently-labelled 
beads, Streptococcus pneumoniae and Mycobacterium 
tuberculosis [102]. Wood smoke exposed macrophages 
demonstrated reduced phagocytosis of fluorescent 
beads, S. pneumoniae and M. tuberculosis with a nega-
tive linear correlation between macrophage particulate 
content and phagocytosis [104]. Furthermore, oxidative 
stress is believed to upregulate expression of  intercel-
lular adhesion molecule-1 (ICAM-1), and platelet acti-
vating factor receptors (PAFR) allowing attachment and 
invasion of respiratory bacteria, including S. pneumo-
niae, Haemophilus influenzae and Pseudomonas aer-
uginosa, which are also important bacterial pathogens in 
COPD [105–107]. Although airway ICAM-1 and PAFR 
expression were markedly upregulated in tobacco smok-
ers and COPD patients, further studies are warranted 
to demonstrate the effect of biomass smoke exposure 
on inducing the expression of these host surface recep-
tors [108–110]. Recently, KC et  al. developed a method 
to generate batches of biomass smoke extracts that can 
be preserved for longer periods for use in multiple expo-
sure experiments, thus minimizing inter-assay variation 
[103]. This will facilitate further research on mechanistic 
role of smoke extracts in the inflammatory response and 
the pathogenesis of respiratory diseases including COPD, 
lung cancer and LRI.
Preventive and therapeutic measures
Biomass smoke is one of the major risk factors for the 
onset/progression of COPD in developing countries 
[61]. To reduce the exposure to smoke generated from 
combustion of biomass fuel, several preventive inter-
ventions have been recommended, with some already 
implemented.
Based on previous intervention studies, the use of 
efficient cooking stoves and the promotion of cleaner 
fuel use  (e.g., biogas, liquefied petroleum gas and elec-
tricity) has been effective in preventing biomass smoke 
exposure, at least to some extent [111–113]. The use of 
improved cooking stoves (ICS) has been found to reduce 
the mean  PM2.5 levels by 63.2% in Nepal, 37.0% Senegal, 
32.8% in the Gambia and 18–45% in Kenya [111, 112, 
114]. Although the decrease in mean  PM2.5 levels was 
significantly high, none of the improved cooking stoves 
achieved the WHO guideline level of mean kitchen  PM2.5 
of 25 µg/m3 for 24-h. A recent 9-year prospective cohort 
study in China evaluated the effect of intervention with 
improved cooking fuels and kitchen intervention [113]. 
Use of clean fuels and improved ventilation were associ-
ated with a lower decline in  FEV1 (12 mL/year, 4–20 mL/
year versus 13  mL/year, 4–23  mL/year) compared to 
those with neither intervention, after adjusting for con-
founders [113]. In addition, the duration of improved 
fuel use and ventilation was negatively correlated with 
the decline of  FEV1 (p < 0.05) [113]. Moreover, the fuel 
and ventilation improvement intervention were associ-
ated with a reduction in the risk of COPD, with an odds 
ratio of 0.28 (95% CI, 0.11–0.73) [113]. Despite the per-
ception that biomass is a cheap fuel source, the annual 
health-related cost per household associated with bio-
mass smoke exposure (16.94 USD) in Nepal is 61.3% 
higher than the annual cost of biogas usage (10.38 USD), 
an alternative cleaner fuel [14]. In addition, the findings 
of the study suggest that providing community educa-
tion and creating rural employment and income genera-
tion opportunities are important measures in promoting 
the sustainable use of clean fuels [14].
In terms of therapeutic intervention, exposure to 
household and outdoor air pollutants are found to reduce 
antioxidant defense by decreasing the levels of ascor-
bate, urate, SOD and reduced glutathione resulting in 
inflammation of the airways [115]. Antioxidants and 
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anti-inflammatory drugs are potential therapeutics for 
the prevention of biomass smoke induced inflammation-
mediated lung injury [116, 117]. Based on the evidence 
that wood and cow dung smoke upregulated the expres-
sion of PAFR on human bronchial epithelial cells, we 
believe that the induction of microbial adhesion recep-
tors on respiratory epithelia could be targeted therapeuti-
cally to prevent LRIs. Several in vitro studies have shown 
that the use of PAFR antagonists such as CV-3988 and 
WEB-2086 abrogates the adhesion of S. pneumoniae and 
nontypeable H. influenzae to cigarette smoke exposed 
human bronchial and alveolar epithelial cells [118, 119]. 
In addition, ICAM-1, a major receptor for rhinoviruses 
and nontypeable H. influenzae could be another impor-
tant target with therapeutic potential [120, 121]. How-
ever, we stress the point that further research is needed 
to elucidate the mechanisms of biomass smoke induced 
susceptibility to LRI, as well as development of COPD 
and lung cancer. But while new therapeutics may be pos-
sible with regard to reducing the progression or symp-
toms of biomass smoke-related lung disease, the major 
focus needs to be maintained on a global reduction in the 
exposure of human populations to biomass smoke.
Strengths and limitations
There are several strengths of our review. Our narrative 
review comes at a time when the United Nations and the 
World Health Organization have specifically focused on 
the urgent need to limit non-communicable diseases, 
which has also garnered support from various Heads-
of-Countries and Governments [122]. In addition, we 
have examined the epidemiology of non-cigarette smoke 
etiologies (biomass smoke, air pollution and multiple 
occupational exposures) implicated in heightened risk of 
developing a range of lung diseases, most notably, COPD, 
lung cancer and respiratory infections. We have reviewed 
and summarized potential mechanisms involved in the 
pathogenesis of non-cigarette smoke exposure and lung 
disease. Finally, we have highlighted the potential pre-
ventive, as well as therapeutic strategies to limit lung dis-
eases related to these exposures.
One of the limitations is that there may be variability 
across epidemiological studies in terms of data collection 
and analyses. In particular, factors such as geographical 
locations, sampling points within a city as well as multi-
ple cities in a specific country, the type of sampling (lon-
gitudinal versus one time-point sampling) contributes 
significantly to heterogeneity of results obtained. In addi-
tion, participant recruitment criteria (i.e., from general 
population or community healthcare centers), reliability 
of self-reported duration of exposure are crucial factors 
that need to be standardized globally. Notably, variabil-
ity of spirometry technique and the threshold cut-off for 
COPD (i.e.,  FEV1/FVC < 0.70 or  FEV1/FVC < LLN) vary 
across studies. In addition, it is difficult to tease out con-
tributions of individual exposure(s)-related causations 
and hence the results may represent disease associated 
with mixed exposures. The heterogeneity in future epide-
miological studies could be addressed by utilizing stand-
ardized and validated research methodologies/strategies 
to ascertain burden of lung diseases associated with 
non-cigarette smoke exposures. We are not concluding 
direct causation of lung diseases due to non-cigarette 
smoke exposures in our review; however, our intent 
was to direct policymakers and researchers towards the 
possible mechanisms reported to date. Clearly, focused 
and detailed mechanistic studies are needed to estab-
lish direct causation of non-cigarette smoke exposures 
and lung pathologies, which should be further validated 
in large-scale epidemiological studies, as well as mecha-
nistic models of experimental animal models. Finally, we 
limited our analysis to published literature and did not 
include media/analytical reports from recently initiated 
preventive strategies (such as Ujjwala yojana in India; 
[123]). However, this could be followed up once the gov-
ernment reports are released by various countries.
Summary and conclusions
The prevalence of COPD amongst non-smokers is a 
worrying concern globally, as almost half the World’s 
population is chronically exposed to biomass smoke, 
air pollution and other exposures (chemicals, dusts, 
and fumes). Evidently, low socio-economic status 
drives large sections of societies living in low- and 
middle-income countries towards biomass fuels for 
cooking/heating purposes. In addition, poor aware-
ness about respiratory health and lack of implementa-
tion of adequate safety measures (e.g., poorly ventilated 
homes) predispose these individuals to heightened risk 
of developing biomass smoke-induced lung diseases, 
including COPD, lung cancer and respiratory infec-
tions. Chronic biomass smoke (and other non-ciga-
rette exposures) delivers deleterious compounds (PMs, 
PAHs etc.) that activate an inflammatory cascade in the 
lungs, which  may potentially spill over systemically. 
This is coupled with marked immune cell dysfunction, 
activation of oncogenes and upregulation of microbial 
receptors in the respiratory tract, which contribute to 
onset/progression of COPD and other related diseases 
(lung cancer and infections). Preventive strategies 
should include awareness about the long-term health 
benefits of using cleaner fuels over biomass-fuels, use 
of more efficient cooking equipment, and the  impor-
tance of adequate ventilation in low socioeconomic 
localities. Although research has only begun to unravel 
the underlying molecular and pathological mechanisms 
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involved in biomass smoke-induced COPD, anti-oxi-
dants, anti-inflammatory and anti-microbial drugs may 
be promising new therapeutics to limit the effects of 
non-smoking related COPD.
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